Sign In
Free Newsletter
Recent Articles from Reuters
Warner Bros Discovery board rejects rival bid from Paramount
LOS ANGELES, Dec 17 (Reuters) – Warner Bros Discovery’s board rejected Paramount Skydance’s $108.4 billion hostile bid on Wednesday, saying it failed to provide adequate financing assurances. In a letter to shareholders, disclosed in a regulatory filing, the board wrote that Paramount had “consistently misled” Warner Bros shareholders that its $30-per-share cash offer[...]
Wall St ends mixed after paring earlier losses
U.S. stocks closed mixed as the Nasdaq rose and the Dow fell, with investors weighing delayed jobs data and the Fed’s 2025 outlook.
Ford retreats from EVs, takes $19.5 billion charge as Trump policies take hold
Dec 15 (Reuters) – Ford Motor said on Monday it will take a $19.5 billion writedown and is killing several electric-vehicle models, in the most dramatic example yet of the auto industry’s retreat from battery-powered models in response to the Trump administration’s policies and weakening EV demand. The Dearborn, Michigan-based company said it will stop […]
Nasdaq seeks to extend trading hours, as Wall Street gears up for 24/7 move
NEW YORK, Dec 15 (Reuters) – Nasdaq, one of the world’s largest exchanges that is home to tech companies Nvidia, Apple and Amazon, is planning to submit paperwork with the U.S. Securities and Exchange Commission on Monday to roll out round-the-clock trading of stocks, as it looks to capitalize on a global demand for U.S. […]
Trump’s $100,000 H-1B visa fee draws legal challenge from US states
California and 18 states are suing to block Trump’s $100K H-1B visa fee, arguing it exceeds federal authority and threatens key industries.
Investors eager for delayed data to shed light on US economy
Delayed U.S. jobs and inflation reports will give markets fresh clarity after a government shutdown as investors assess Fed policy and year-end risks.
Trump’s semiconductor tariff plan likely delayed, officials say
US officials signal Trump’s planned 100% semiconductor tariffs may be delayed as the administration weighs China tensions and consumer price risks.
Novo Nordisk chair touts OTC future for Wegovy as top investor tightens grip
New Novo Nordisk chair Lars Rebien Sorensen plans to add pharma and OTC expertise after a board shake-up that sparked governance concerns.
Texas judge weighs Paxton bid to block Kenvue dividend
Texas AG Ken Paxton seeks to block Kenvue’s $398M dividend and restrict Tylenol marketing as a judge considers his unprecedented request.
US House report accuses China of minerals market interference
A House committee report alleges China manipulates global critical minerals prices and urges new U.S. policy controls and oversight.
